comparemela.com

Latest Breaking News On - Biotechnology holdings - Page 4 : comparemela.com

Lixte Biotechnology Shares Rise 25% on LB-100 Cancer Treatment Research

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Alnylam Pharmaceuticals (NASDAQ:ALNY), Acumen Pharmaceuticals (NASDAQ:ABOS)

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.

China
Tianjin
Peru
Ohio
United-states
Netherlands
Jiuzi
Zhejiang
Puyi
Guizhou
Utime-limited
Farfetch-limited

Lixte Biotechnology (NASDAQ:LIXT) Stock Price Up 15.6%

Shares of Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Free Report) rose 15.6% during trading on Tuesday . The stock traded as high as $7.00 and last traded at $6.01. Approximately 305,545 shares traded hands during mid-day trading, an increase of 294% from the average daily volume of 77,471 shares. The stock had previously closed at […]

Geode-capital-management
Ep-wealth-advisors
Ethos-financial-group
Lixte-biotechnology-holdings-inc
Nasdaq
Renaissance-technologies
Lixte-biotechnology-holdings
Free-report
Biotechnology-trading-down
Financial-group
Lixte-biotechnology

Short Interest in Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Expands By 306.7%

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Free Report) was the recipient of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 12,200 shares, an increase of 306.7% from the May 31st total of 3,000 shares. Approximately 1.5% of the shares of the company are […]

Renaissance-technologies
Ep-wealth-advisors
Ethos-financial-group
Geode-capital-management
Lixte-biotechnology-company-profile
Nasdaq
Lixte-biotechnology-holdings-inc
Lixte-biotechnology-holdings
Free-report
Lixte-biotechnology
Capital-management

Cizzle subscription raises GBP350,000 to fund development pipeline

Cizzle Biotechnology Holdings PLC said on Monday that it raised GBP350,000 from a subscription of 16.7 million shares at 2.1 pence per share, with new and existing investors. The London-based. | June 12, 2023

London
City-of
United-kingdom
Allan-syms
Cizzle-biotechnology-holdings
Alliance-news
Alliance-news-ltd
Biotechnology-holdings
Chair-allan-syms
Cizzle-biotechnology
Will-neill
All-rights

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.